Author:
Iwasaka Chiharu,Ninomiya Yuka,Nakagata Takashi,Nanri Hinako,Watanabe Daiki,Ohno Harumi,Tanisawa Kumpei,Konishi Kana,Murakami Haruka,Tsunematsu Yuta,Sato Michio,Watanabe Kenji,Miyachi Motohiko
Abstract
AbstractEscherichia coli harboring polyketide synthase (pks+E. coli) has been suggested to contribute to colorectal cancer development. Physical activity is strongly associated with lower colorectal cancer risks, but its effects on pks+E. coli remain unclear. The aim of this study was to investigate the association between pks+E. coli prevalence and physical activity. A cross-sectional study was conducted on 222 Japanese adults (27–79-years-old, 73.9% female). Triaxial accelerometers were used to measure light-intensity physical activity, moderate-to-vigorous intensity physical activity, the physical activity level, step-count, and time spent inactive. Fecal samples collected from participants were used to determine the prevalence of pks+E. coli. Multivariate logistic regression analysis and restricted cubic spline curves were used to examine the association between pks+E. coli prevalence and physical activity. The prevalence of pks+E. coli was 26.6% (59/222 participants). The adjusted odds ratios (ORs) and 95% confidence intervals (CIs) for the highest tertile with reference to the lowest tertile of physical activity variables were as follows: light-intensity physical activity (OR 0.63; 95% CI 0.26–1.5), moderate-to-vigorous intensity physical activity (OR 0.85; 95% CI 0.39–1.87), physical activity level (OR 0.69; 95% CI 0.32–1.51), step-count (OR 0.92; 95% CI 0.42–2.00) and time spent inactive (OR 1.30; 95% CI 0.58–2.93). No significant dose–response relationship was found between all physical activity variables and pks+E. coli prevalence. Our findings did not suggest that physical activity has beneficial effects on the prevalence of pks+E. coli. Longitudinal studies targeting a large population are needed to clarify this association.
Funder
Japan Society for the Promotion of Science
The Health and Labor Sciences Research Grant
The Development of Innovative Research on Cancer Therapeutics from Japan Agency for Medical Research and Development
Publisher
Springer Science and Business Media LLC